Francesco Di Costanzo

Phase III Randomized Trial Comparing Three Platinum-Based Doublets in Advanced Non–Small-Cell Lung Cancer

Giorgio V. Scagliotti, Filippo de Marinis, Monica Rinaldi et al. · Journal of Clinical Oncology · 2002 · 891 citations

Medicine, Oncology, Pharmacology +13

Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3

Eric Van Cutsem, Roberto Labianca, G. Bodoky et al. · Journal of Clinical Oncology · 2009 · 468 citations

Medicine, Oncology, Pharmacology +17

Clinical determinants of survival in patients with 5-fluorouracil- based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients

C.-H. Köhne, David Cunningham, Francesco Di Costanzo et al. · Annals of Oncology · 2002 · 458 citations · Full text

Medicine, Biostatistics, Oncology +12

Gemcitabine and Cisplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Randomized Phase III Study of the Italian Lung Cancer Project

Lucio Crinò, Giorgio V. Scagliotti, Serafino Ricci et al. · Journal of Clinical Oncology · 1999 · 366 citations

Medicine, Oncology, Pharmacology +17

Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial

Chiara Cremolini, Carlotta Antoniotti, Daniele Rossini et al. · The Lancet Oncology · 2020 · 325 citations · Full text

Medicine, Oncology, Pharmacotherapy +8